10-K: JBT Marel Reports Transformative Growth Post-Marel Merger
Annual Report
JBT Marel Corporation announced its 2025 annual results, highlighting significant revenue growth driven by the Marel acquisition and strategic realignment into two new segments.
Summary
- Completed the acquisition of Marel hf. on January 2, 2025, for a total consideration of $4.4 billion, creating a leading global food and beverage technology solutions provider.
- Total revenue increased by 121.3% to $3,798.2 million in 2025, primarily due to the Marel acquisition ($1,966.0 million) and organic growth ($39.8 million).
- Realigned reportable segments into Protein Solutions and Prepared Food and Beverage Solutions during the fourth quarter of 2025.
- Reported a net loss of $50.5 million in 2025, a significant decline from a net income of $85.4 million in 2024, primarily due to higher pension expense, interest expense, and acquisition-related costs.
- Adjusted EBITDA from continuing operations increased by 103.5% to $600.4 million in 2025.
- Gross profit margin decreased by 140 basis points to 35.1% in 2025, impacted by tariff effects and operating inefficiencies on certain projects.
- Implemented the JBT Marel 2025 Integration restructuring plan with estimated costs of $55.0 million to $60.0 million and expected cumulative cost savings of $65.0 million to $75.0 million.
- Inbound orders from continuing operations increased to $3,842.7 million in 2025, and order backlog grew to $1,372.0 million.
- Terminated the U.S. qualified defined benefit pension plan on February 4, 2025, resulting in a $146.9 million settlement charge.
- Issued $575.0 million aggregate principal amount of 0.375% Convertible Senior Notes due 2030 on September 9, 2025.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a transformative period with significant strategic growth through acquisition, but short-term profitability was negatively impacted by integration costs, increased debt expenses, and one-time charges. The long-term outlook is positive if synergies are realized and margins improve.
Positives
- Significant revenue growth of 121.3% to $3,798.2 million in 2025, largely driven by the Marel acquisition.
- Adjusted EBITDA increased by 103.5% to $600.4 million, reflecting the expanded scale and synergies from the Marel acquisition.
- Strong demand, particularly for poultry solutions, and healthy backlog conversion contributed to performance.
- Resilient demand for aftermarket parts and service products, generating approximately 50% of total revenue from recurring revenue.
- Successful execution of margin improvement initiatives and synergy savings contributed to Adjusted EBITDA.
- Order backlog increased by $651.5 million to $1,372.0 million, indicating strong future revenue potential.
- Secured takeout financing with a $1.8 billion revolving credit facility and a $900 million Senior Secured Term Loan B.
- Maintained compliance with all covenants in the Second A&R Credit Agreement.
- Pension plan termination completed without requiring additional cash contribution from the Company.
Negatives
- Reported a net loss of $50.5 million in 2025, a significant decline from $85.4 million net income in 2024.
- Gross profit margin decreased by 140 basis points to 35.1% due to tariff impacts and operating inefficiencies on select projects within the Prepared Food and Beverage Solutions segment.
- Pension expense, other than service cost, increased significantly by $121.2 million, primarily due to a $146.9 million settlement charge from the U.S. qualified defined benefit pension plan termination.
- Interest expense increased by $95.0 million due to a higher average debt balance from additional borrowings to fund the Marel acquisition.
- Incurred a loss on investment of $10.6 million in 2025.
- M&A related costs, including integration costs, totaled $114.5 million, impacting profitability.
- Restructuring expense increased to $29.3 million from $1.4 million in 2024.
- Adjusted EBITDA margin decreased by 140 basis points to 15.8%.
- Inbound orders on a constant currency basis decreased by $130.0 million, suggesting a potential organic slowdown excluding the Marel acquisition impact.
Risks
- Fluctuations in financial results due to volatility in demand, sales cycles, and economic conditions.
- Termination or loss of major customer contracts and risks associated with fixed-price contracts, particularly during periods of high inflation.
- Catastrophic loss at any of the Company's facilities or disruption to information systems.
- Loss of key management and other personnel.
- Inability to remediate identified material weaknesses in Marel's internal control over financial reporting.
- Deterioration of economic conditions, including impacts from supply chain delays, reduced material or component availability, and inflationary pressures.
- Changes in food consumption patterns, regulatory developments, adverse weather conditions, natural disasters, or outbreaks of animal-borne or food-borne illnesses.
- Work stoppages by unionized or non-union labor force.
- Inability to compete effectively in highly competitive markets.
- Disruptions in the political, regulatory, economic, and social conditions of the countries in which the Company conducts business.
- Adverse effects from tariffs, trade sanctions, or similar government actions.
- Potential liability arising out of litigation, investigations, or the installation or use of the Company's systems.
- Impact of climate change and environmental protection initiatives.
- Risks related to acquisitions, such as the ability to integrate acquired businesses and realize expected benefits and synergies.
- Inability to rapidly and successfully develop and introduce new or enhanced products and services and keep pace with technological developments, including artificial intelligence and machine learning.
- Difficulties in developing, preserving, and protecting intellectual property or defending claims of infringement.
- Cybersecurity risks arising out of breaches of security relating to sensitive company, customer, and employee information.
- Potential dilutive impact on common stock from convertible note hedge and warrant transactions.
- Counterparty risk with respect to convertible note hedge transactions.
- Maintenance of two stock exchange listings potentially affecting liquidity and resulting in pricing differentials.
- Increased indebtedness following the Marel Transaction, which could adversely impact operational flexibility and increase borrowing costs.
- Risk of goodwill and intangible asset impairments.
- Corporate governance documents and Delaware law provisions that may delay or discourage takeovers and business combinations.
Future Outlook
JBT Marel anticipates year-over-year revenue growth for full year 2026, driven by effective backlog conversion and healthy demand. The company is focused on improving year-over-year margins through ongoing execution of synergy cost savings projects, volume leverage, and continuous improvement efficiencies. Capital expenditures are expected to be between $105 million and $115 million during 2026, with additional integration and synergy-related costs projected at $45 million to $55 million. Cash flows from continuing operations are expected to be sufficient to meet principal cash requirements.
Management Comments
- "Our 2025 financial performance was driven by strong demand, particularly for poultry solutions, healthy backlog conversion, and successful execution of margin improvement initiatives."
- "We experienced resilient demand for our aftermarket parts and service products, generating approximately 50% of total revenue from recurring revenue."
- "JBT Marels margin performance benefited from realized synergy savings and continuous improvement initiatives."
- "For full year 2026 we believe that effective backlog conversion and healthy demand will help deliver year-over-year revenue growth."
- "We are also focused on improving year-over-year margins through ongoing execution of synergy cost savings projects coupled with volume leverage and continuous improvement efficiencies."
Industry Context
StockSavvy.ai notes that the Marel acquisition significantly expands JBT's footprint in the global food and beverage technology solutions market, particularly in animal protein processing (poultry, meat, fish) and downstream value-added preparation. This move positions the combined entity, JBT Marel, as a more diversified and leading player, leveraging complementary product portfolios and cutting-edge technology. The focus on recurring revenue (50% of total revenue in 2025) aligns with broader industry trends towards service-oriented models and long-term customer relationships, providing stability amidst capital expenditure cycles. The strategic realignment into Protein Solutions and Prepared Food and Beverage Solutions reflects an industry trend towards specialized, integrated solutions across the food production value chain, from primary processing to packaging.
Comparison to Industry Standards
- JBT Marel's major competitors include Advanced Equipment Inc., Baader GmbH & Co. KG, GEA Group AG, Krones, Meyn Food Processing Technology B.V., and Tetra Laval.
- The company competes by leveraging industry expertise to provide differentiated and proprietary technology, integrated systems, high product quality and reliability, and comprehensive aftermarket services for its installed base of equipment.
- JBT Marel strives to provide equipment that delivers a lower total cost of ownership, distinguishing itself by offering reliable uptime, labor reduction through automation, increased yields, improved product quality, and support for environmental goals (e.g., lowering energy and water usage, reducing food waste, enhancing food safety).
- Its global presence, with operations in more than 30 countries and local personnel, differentiates it from regional competitors.
- The acquisition of Marel, a multi-national food processing company, aims to create a leading global food and beverage technology solutions provider, suggesting a strategic move to consolidate market share and enhance competitive positioning against other large multinational players in the industry.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| President | N/A (new role for combined entity) | Arni Sigurdsson | January 2025 | Appointment upon closing of Marel Transaction. |
| Executive Vice President, General Counsel and Secretary | N/A | James C. Pelletier | June 2025 | Appointment to the role. |
| Executive Vice President, Regions and Integration | Executive Vice President and President, Diversified Food and Health | Luiz Augusto Rizzolo | January 2025 | Reassignment of role following Marel Transaction. |
| Executive Vice President, Poultry | Executive Vice President Poultry at Marel | Roger Claessens | January 2025 | Appointment following the close of the Marel Transaction. |
| Executive Vice President and President, Diversified Food & Health | President of JBT Diversified Food & Health North America | Mary Beth Siddons | January 2025 | Appointment following the close of the Marel Transaction. |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Anti-Takeover Provisions | The company's certificate of incorporation and by-laws contain provisions that could make acquisition more difficult, including limitations on stockholder removal of directors, board's right to issue preferred stock without stockholder approval, inability of stockholders to act by written consent, advance notification requirements for stockholder nominations/proposals, no cumulative voting, and only the board may call special meetings. Amendments to certain provisions require approval by holders of at least 80% of outstanding common stock. | January 2, 2025 (effective date of Third Amended and Restated Certificate of Incorporation and Fourth Amended and Restated By-Laws) | These provisions are expected to discourage coercive takeover practices and inadequate takeover bids, encouraging negotiation with the board and potentially protecting management continuity, but may also deprive stockholders of opportunities to sell shares at higher prices. |
| Delaware Law Applicability | The company is subject to Section 203 of the Delaware General Corporation Law, which prohibits business combinations with an interested stockholder for three years unless approved in a prescribed manner. | N/A (ongoing applicability) | Further discourages hostile takeovers by limiting business combinations with significant shareholders for a three-year period. |
| Insider Trading Policy Update | Updated Insider Trading Policy (G.310) on May 14, 2025, prohibiting hedging transactions, margin or pledging transactions, short sales, sales against the box, derivatives (with exceptions for stock option exercises), and standing orders for all employees and directors. | May 14, 2025 | Enhances compliance with federal securities laws and protects the company's reputation by preventing actual or apparent insider trading and conflicts of interest. |
| Trading Pre-clearance and Plans | Directors and Officers require pre-clearance from designated officers before trading company securities. Rule 10b5-1 trading plans also require pre-approval. | May 14, 2025 (updated policy) | Strengthens internal controls over insider trading and ensures compliance with SEC regulations, reducing legal and reputational risks. |
| Cybersecurity Oversight | The Audit Committee reviews cybersecurity information technology risks in connection with its oversight of the enterprise risk management program and reports to the Board quarterly. Material cybersecurity events are reported to the Audit Committee and Board of Directors. | N/A (ongoing practice) | Provides robust oversight of cybersecurity risks, aiming to protect information assets and ensure business continuity, thereby mitigating potential financial and reputational damage from cyber incidents. |
Legal Proceedings
- The company is involved in legal proceedings arising in the ordinary course of business.
- Management believes that the resolution of these proceedings, individually or taken as a whole, will not have a material adverse effect on the company's business, results of operations, cash flows, or financial condition.
- Liabilities for pending legal claims are established only when losses are judged to be probable and reasonably estimable.
Related Party Transactions
- The company is a party to agreements to lease manufacturing facilities from entities owned by certain employees who were former owners or employees of acquired businesses.
- As of December 31, 2025, the operating lease right-of-use asset and the lease liability related to these agreements were $2.8 million.
- As of December 31, 2024, the operating lease right-of-use asset and the lease liability related to these agreements were $3.5 million.
Stakeholder Impact
- Shareholders: Experienced a net loss in 2025, but the Marel acquisition offers long-term growth potential. Increased debt and potential dilution from convertible notes and warrants are factors. Anti-takeover provisions may limit opportunities for premium acquisition offers.
- Employees: Integration of JBT and Marel, along with restructuring plans, may lead to organizational changes. The company emphasizes a values-driven workplace, safety, well-being, talent development, and competitive total rewards.
- Customers: Benefit from an expanded global food and beverage technology solutions provider with complementary product portfolios and cutting-edge technology, aiming for increased yields, efficiency, and food safety. Some projects faced tariff impacts and operating inefficiencies.
- Suppliers: Face ongoing challenges related to supply chain disruptions and increased raw material costs.
- Creditors: The company's indebtedness increased substantially post-Marel acquisition, but it remains in compliance with all debt covenants, indicating sound financial management of its obligations.
Next Steps
- Continue the integration of JBT and Marel businesses to realize anticipated benefits and synergies.
- Execute synergy cost savings projects and continuous improvement efficiencies to improve margins in 2026.
- Focus on effective backlog conversion and healthy demand to deliver year-over-year revenue growth in 2026.
- Incur integration costs and other synergy-related costs in the range of $45 million to $55 million during 2026.
- Anticipate capital expenditures between $105 million and $115 million during 2026.
- Remediate identified material weaknesses in Marel's internal control over financial reporting.
- Brian Deck's trading plan for the sale of up to 18,634 shares of common stock, with the first sale permitted on March 2, 2026, and the plan terminating on November 16, 2026.
Key Dates
| Date | Description |
|---|---|
| May 28, 2021 | Closed a private offering of $402.5 million 0.25% Convertible Senior Notes due 2026 and entered into related hedge and warrant transactions. |
| August 1, 2023 | Completed the sale of the AeroTech business segment. |
| December 31, 2024 | Operating lease right-of-use asset and lease liability related to related party agreements were $3.5 million. |
| January 2, 2025 | Completed the acquisition of Marel hf., changed corporate name to JBT Marel Corporation and stock ticker to JBTM, and secured takeout financing including a $900 million Senior Secured Term Loan B and an increased revolving credit facility to $1.8 billion. |
| January 3, 2025 | JBTM common stock commenced trading on both NYSE and Nasdaq Iceland. Entered into five cross-currency swaps expiring in January 2032. |
| February 4, 2025 | Acquired the remaining 2.5% of Marel's issued and outstanding common shares (Squeeze out) and completed the termination of the U.S. qualified defined benefit pension plan. |
| September 3, 2025 | Amended the Second A&R Credit Agreement to reduce the pricing applicable to the revolving credit facility. |
| September 9, 2025 | Closed a private offering of $575.0 million 0.375% Convertible Senior Notes due 2030 and entered into related hedge and warrant transactions. |
| December 31, 2025 | Operating lease right-of-use asset and lease liability related to related party agreements were $2.8 million. |
| January 2, 2026 | Maximum secured leverage ratio under the Second A&R Credit Agreement stepped down to 4.0x. |
| February 23, 2026 | Date of executive officer ages and common stock outstanding shares (51,982,204). |
| March 2, 2026 | First sale permitted under CEO Brian Deck's Rule 10b5-1 trading plan. |
| May 15, 2026 | Maturity date for the 2026 Convertible Senior Notes. |
| August 2026 | Expiration of the 2026 Warrants. |
| November 16, 2026 | Termination date for CEO Brian Deck's Rule 10b5-1 trading plan. |
| September 15, 2030 | Maturity date for the 2030 Convertible Senior Notes. |
| January 2, 2032 | Maturity date for the Senior Secured Term Loan B. |
Recommendation
holdThe Marel acquisition represents a significant strategic expansion, positioning JBT Marel as a leading global player in food and beverage technology. While the substantial revenue growth and increased Adjusted EBITDA are positive, the reported net loss, decreased gross profit margin, and significant increase in debt and associated interest expenses indicate short-term integration challenges and financial strain. The identified material weaknesses in Marel's internal controls add a layer of operational risk. A 'Hold' recommendation is appropriate as the company navigates the complex integration process and works to realize the anticipated synergies and margin improvements, which are crucial for long-term value creation. Investors should monitor the remediation of internal control weaknesses and the progress of synergy realization.
Keywords
Food processing equipment, Food and beverage technology, Marel acquisition, Protein Solutions, Prepared Food and Beverage Solutions, Convertible Senior Notes, SEC 10-K, Financial results, Corporate governance, Risk factors, Supply chain, Cybersecurity, ESG, Automation, Aftermarket services, Debt financing, Restructuring
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.